维普中文期刊产品整合服务
79篇 您的检索式:作者名="P Gionchetti"
    题名 作者 年代 出处 被引量
1Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophills and regulation by interleukin 10 during intestinal inflammation显示文摘Increasedsecretionofproinflammatorycytokinesbycirculatingpolymorphonuclearneutrophilsandregulationbyinterleukin10duringintes...S Nikolaus 1, J Bauditz 1, P Gionchetti 2, C Witt 3, H Lochs 1 and S Schreiber 1 1Charité University Hospital, 4th Medical Department, Humboldt University, Berlin, Germany 2Clinica Media I, Policlinico S. Orsola, University of Bolog 1998World Journal of Gastroenterology1998,4,3:17
2Combined carriership of TLR9 -1237C and CD14 -260T alleles enhances the risk of developing chronic relapsing pouchitis显示文摘AIM: To investigate the single nucleotide polymorphisms (SNPs) in genes involved in bacterial recognition and the susceptibility to pouchitis or pouchitis severity.METHODS: Analyses of CD14 -260C>T, CARD15/NOD2 3020insC, Toll-like receptor (TLR)4 +896A>G,TLR9 -1237T>C, TLR9+ 2848G>A, and IRAKM +22148G>A SNPs were performed in 157 ileal-pouch anal anastomosis (IPAA) patients (79 patients who did not develop pouchitis, 43 infrequent pouchitis patients,35 chronic relapsing pouchitis patients) and 224 Italian Caucasian healthy controls.RESULTS: No significant differences were found in SNP frequencies between controls and IPAA patients.However, a significant difference in carriership frequency of the TLR9-1237C allele was found between the infrequent pouchitis and chronic relapsing pouchitis groups [P = 0.028, odd's ratio (OR) = 3.2, 95%CI = 1.2-8.6].This allele uniquely represented a 4-locus TLR9 haplotype comprising both studied TLR9 SNPs in Caucasians.Carrier trait analysis revealed an enhanced combined carriership of the alleles TLR9 -1237C and CD14 -260T in the chronic relapsing pouchitis and infrequent pouchitis group (P = 0.018, OR = 4.1, 95%CI = 1.4 -12.3).CONCLUSION: There is no evidence that the SNPs predispose to the need for IPAA surgery. The significant increase of the combined carriership of the CD14 -260T and TLR9 -1237C alleles in the chronic relapsing pouchitis group suggests that these markers identify a subgroup of IPAA patients with a risk of developing chronic or refractory pouchitis.KM Lammers S Ouburg SA Morré JBA Crusius P Gionchetti F Rizzello C Morselli E Caramelli R Conte G Poggioli M Campieri AS Pea 2005World Journal of Gastroenterology2005,11,46:7
3Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis : a double-blind, placebo-controlled trial 显示文摘Gionchetti P Rizzello F Venturi A 2000Gastroenterology2000,119,:1
4Prophylaxis of pouchitis onset with probiotic therapy : a double-blind, placebo-controlled trial 显示文摘GIONCHETTI P RIZZELLO F HELWlG U 2003Gastroenter- ology2003,124,5:1
5Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis:a double-blind,placebo-controlled trial显示文摘GIONCHETTI P RIZZELLO F VENTURI A 2000Gastroenterology2000,119,2:1
6Bacteria as the cause of ulcerativecolitis显示文摘 Gionchetti P 2001Gut2001,48,:1
7Oral beclomethasone dipropionate in patients with mild to moderate ulcerative colitis:a dose-finding study显示文摘RIZZELLO F GIONCHETTI P GALEAZZI R 2001Adv Ther2001,18,6:1
8Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis 显示文摘Venturi A Gionchetti P Rizzello F 1999Aliment Pharmacol Ther1999,13,8:1
9Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis显示文摘Gionchetti P Rizzello F Venturi A 1998Dis Colon Rectum1998,41,1:1
10Prophylaxis of pouchitis onset with Probiotic therapy:a double-hlind,placebo-controlled trial显示文摘Gionchetti P Rizzello F Helwig U 2003Gastroenterology2003,124,5:1
11Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial显示文摘GIONCHETTI P RIZZELLO F HELWIG U 2003Gastroenterology2003,124,5:1
12Obscure gastrointestinal bleeding: single centre experience of capsule endoscopy 显示文摘Calabrese C Liguori G Gionchetti P 2013Intern Emerg Med2013,8,8:1
13Rectal dialysate and fecal concentra- tion of neutrophil gelatinase associated li- pocalin, inter leukin-8, and tumor necrosis factor-alpha in ulcerative colitis显示文摘Nielsen OH Gionchetti P Ainsworth M 1999Am J Gastroenterol1999,94,10:1
14Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis 显示文摘Venturi A Gionchetti P Rizzello F 1999Aliment Pharmacol Ther1999,13,8:1
15Rifaximin systemic absorption in patients with ulcerative colitis显示文摘Rizzello F Gionchetti P Venturi A 1998Eur J Clin Pharmacol1998,54,:1
16Rifaximin systemic absorption in patients with ulcerative colitis 显示文摘Rizzello F Gionchetti P VENTURI A 1998Eur J Clin Pharmacol1998,54,1:1
17Standard treatment of ulcerativecolitis显示文摘Gionchetti P RizzeUo F Habal F 2003Dig Dis2003,21,2:1
18Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial显示文摘Gionchetti P Rizzello F Venturi A 2000Gastroenterology2000,119,:1
19Rectal dialysate and fecal concentration of neutrophil gelati- nase-associated lipocalin,interleukin-8, and tumor ne- crosis factor-alpha in ulcerative colitis显示文摘Nielsen 0 H Gionchetti P Ainsworth M 1999Am J Gastr- oenterol1999,94,10:1
20Medical treatment of severe ulcerative colitis显示文摘Rizzello F Gionchetti P Venturi A 0,,2:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费